Want to join the conversation?
During 4Q15, $TMO's Specialty Diagnostics Segment revenue increased to $865MM vs. $863MM in 4Q14. Segment adjusted operating margin was 26.2% vs. 27.1% in the 2014 quarter. Laboratory Products & Services Segment revenue grew 8% to $1.82Bil vs. $1.68Bil in 4Q14. Segment adjusted operating margin increased to 14.7% vs. 14.5% in the 2014 quarter.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.